摘要
卵巢卵泡膜–纤维瘤组(ovarian thecoma-fibroma groups, OTFG)肿瘤是一种罕见的性索间质来源肿瘤,通常为良性。临床上误诊率比较高,合并胸腹水或CA125升高时容易误诊为恶性肿瘤,肿瘤较大时与浆膜下肌瘤难以鉴别,术前的诊断影响治疗方案的选择,尤其是对于育龄期女性,能否保留卵巢功能而选择肿瘤切除,因此进行准确的术前诊断对临床治疗和管理策略具有重要意义。超声仍然是对女性卵巢肿瘤术前的最常用的诊断方法。本文就超声对OTFG患者的术前诊断价值的相关研究进展展开综述。Ovarian thecoma-fibroma groups (OTFG) tumors are a rare sex cord-stromal derived tumor, which is usually benign. The misdiagnosis rate is relatively high clinically. When combined with pleural effusion or elevated CA125, it is easy to be misdiagnosed as a malignant tumor. When the tumor is large, it is difficult to distinguish it from subserosal fibroids. Preoperative diagnosis affects the choice of treatment options, especially for women of childbearing age. Whether the ovarian function can be preserved and tumor resection can be chosen, so accurate preoperative diagnosis is of great significance to clinical treatment and management strategies. Ultrasound is still the most commonly used preoperative diagnostic method for female ovarian tumors. This article reviews the research progress on the preoperative diagnostic value of ultrasound in patients with OTFG.
出处
《临床个性化医学》
2024年第3期752-756,共5页
Journal of Clinical Personalized Medicine